Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.63
-0.28 (-14.66%)
At close: Aug 15, 2025, 3:59 PM
1.50
-7.98%
After-hours: Aug 15, 2025, 06:40 PM EDT
Trinity Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15.86M | 15.15M | 15.84M | 14.7M | 13.43M | 14.68M | 13.9M | 14.83M | 18.04M | 19.5M | 18.46M | 18.78M | 19.52M | 22M | 25.84M | 25.59M |
Cost of Revenue | 10.98M | 9.84M | 10.11M | 9.71M | 9.32M | 10.4M | 8.87M | 9.26M | 11.8M | 17.49M | 11.94M | 11.51M | 12.29M | 13.1M | 14.82M | 14.68M |
Gross Profit | 4.88M | 5.31M | 5.73M | 5M | 4.11M | 4.28M | 5.03M | 5.57M | 6.24M | 2.02M | 6.53M | 7.27M | 7.24M | 8.9M | 11.03M | 10.91M |
Operating Income | -11.51M | -2.56M | -4.05M | -3.07M | -3.49M | -4.5M | -14.85M | -3.92M | -4.78M | -4.8M | -1.51M | -10.19M | -1.25M | 2.75M | 6.29M | 3.08M |
Interest Income | n/a | 848K | n/a | 55K | n/a | 389K | 62K | 154K | 112K | 329K | n/a | 218K | n/a | 194K | 1K | 1K |
Pretax Income | -15.8M | -4.79M | -6.89M | -3.25M | -5.5M | -6.5M | -18.61M | -6.32M | -10.09M | -8.94M | -20.09M | -2.07M | 486K | 1.55M | 5.08M | 1.87M |
Net Income | -16.96M | -4.76M | -6.76M | -3.32M | -5.5M | -6.72M | -5.99M | -6.3M | -10.08M | -8.94M | -20.06M | -1.92M | 1.67M | 1.32M | -783K | 1.6M |
Selling & General & Admin | 8.37M | 6.52M | 6.42M | 6.98M | 6.48M | 7.68M | 7.91M | 8.63M | 10.19M | 5.79M | 7.06M | 6.13M | 5.33M | 6.13M | 6.59M | 6.4M |
Research & Development | 1.45M | 1.01M | 991K | 1.09M | 1.12M | 1.17M | 1.23M | 860K | 1.17M | 1.02M | 984K | 965K | 941K | 1.06M | 1.06M | 1.44M |
Other Expenses | 6.57M | 339K | 2.37M | n/a | n/a | n/a | n/a | n/a | -341K | -1K | 1K | -1K | -722K | -1.04M | -2.91M | -1K |
Operating Expenses | 16.39M | 7.87M | 9.79M | 8.06M | 7.6M | 8.78M | 9.07M | 9.49M | 11.01M | 6.81M | 8.04M | 7.1M | 5.55M | 6.15M | 4.74M | 7.83M |
Interest Expense | 5.78M | 3.08M | 2.84M | 264K | 1.73M | 2.39M | 3.82M | 2.55M | 2.4M | 2.18M | 8.3M | 2.24M | 3.47M | 1.36M | 1.2M | 1.21M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.37M | 17.71M | 19.89M | 17.77M | 16.92M | 19.18M | 17.93M | 18.75M | 22.81M | 24.3M | 19.98M | 18.6M | 17.84M | 19.26M | 19.56M | 22.52M |
Income Tax Expense | 585K | -35K | -131K | 67K | -3K | 222K | -267K | -11K | -16K | 3K | -30K | -150K | -1.19M | 260K | 655K | 105K |
Shares Outstanding (Basic) | 14.17M | 10.39M | 9.47M | 8.87M | 7.64M | 7.67M | 7.66M | 7.63M | 7.62M | 7.62M | 5.9M | 5.9M | 4.18M | 4.18M | 4.18M | 4.18M |
Shares Outstanding (Diluted) | 14.17M | 10.39M | 9.47M | 8.87M | 7.67M | 7.67M | 7.66M | 7.63M | 7.62M | 7.62M | 6.44M | 6.44M | 5.25M | 4.37M | 4.18M | 4.53M |
EPS (Basic) | -1.2 | -0.46 | -0.71 | -0.37 | -0.72 | -0.88 | -0.78 | -0.83 | -1.32 | -1.17 | -3.4 | -0.33 | 0.40 | 0.06 | -0.19 | 0.08 |
EPS (Diluted) | -1.2 | -0.46 | -0.71 | -0.37 | -0.72 | -0.88 | -0.78 | -0.83 | -1.32 | -1.17 | -3.2 | -0.3 | 0.32 | 0.06 | -0.19 | 0.07 |
EBITDA | -9.6M | -1.11M | -3.9M | -2.29M | -3.03M | -3.88M | -14.31M | -3.16M | -7.03M | -6.01M | -1.17M | -338K | -5.33M | 2.55M | 7.29M | 3.61M |
EBIT | -10.02M | -1.71M | -4.05M | -2.99M | -4.11M | -4.11M | -14.79M | -3.77M | -7.7M | -7.8M | -1.85M | -998K | -5.91M | 1.75M | 6.29M | 3.08M |
Depreciation & Amortization | 424K | 598K | 153K | 691K | 462K | 229K | 484K | 602K | 668K | 744K | 261K | 700K | 1.94M | 800K | 1M | 800K |